Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.

Saved in:
Bibliographic Details
Title: Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting.
Authors: Gohil R; National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Diabetes Nursing, King's College London, London, UK., Crosby-Nwaobi R; National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Diabetes Nursing, King's College London, London, UK., Forbes A; Diabetes Nursing, King's College London, London, UK., Burton BJ; Ophthalmology Department, James Paget University Hospital, Great Yarmouth, UK., Hykin P; National Institute for Health Research Moorfields Biomedical Research Centre, London, UK., Sivaprasad S; National Institute for Health Research Moorfields Biomedical Research Centre, London, UK; Laser and Retinal Research Unit, King's College Hospital, London, UK.
Source: Patient preference and adherence [Patient Prefer Adherence] 2016 May 26; Vol. 10, pp. 949-55. Date of Electronic Publication: 2016 May 26 (Print Publication: 2016).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475748 Publication Model: eCollection Cited Medium: Print ISSN: 1177-889X (Print) Linking ISSN: 1177889X NLM ISO Abbreviation: Patient Prefer Adherence Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1177-889X
DOI:10.2147/PPA.S105536